Core Viewpoint - The company has approved guarantees for its wholly-owned subsidiaries, Guizhou Daqin Tumor Hospital Co., Ltd. and Guizhou Chitianhua Tongzi Chemical Co., Ltd., totaling up to 1.7 billion yuan for 2024, with a cumulative guarantee balance of 1.17 billion yuan as of March 31, 2025 [1][15]. Summary by Sections Guarantee Overview - The company approved a guarantee of up to 1.7 billion yuan for its subsidiaries during the 2024 annual shareholder meeting, with a total guarantee limit of 2.85 billion yuan for the year [1][15]. - The company has provided a cumulative guarantee balance of 616.50 million yuan for Daqin Hospital and 553.60 million yuan for Tongzi Chemical as of March 31, 2025 [1][15]. Subsidiary Information - Guizhou Daqin Tumor Hospital Co., Ltd. has total assets of 1.19 billion yuan and liabilities of 745.12 million yuan as of December 31, 2023, with a net loss of 11.63 million yuan for the year [3][4]. - Guizhou Chitianhua Tongzi Chemical Co., Ltd. has total assets of 2.35 billion yuan and liabilities of 989.72 million yuan as of December 31, 2023, with a net profit of 997.96 million yuan for the year [6]. Guarantee Agreements - The company has entered into a guarantee agreement with Guiyang Bank for Daqin Hospital, with a principal amount of 29 million yuan [7][9]. - A separate agreement with Zhongxin Bank for Tongzi Chemical includes a maximum principal amount of 145 million yuan [11][12]. Necessity and Reasonableness of Guarantees - The guarantees are deemed necessary to support the subsidiaries' daily operations, with the company maintaining control over their operational risks and creditworthiness [15]. - The total external guarantees represent 43.80% of the company's latest audited net assets, with no overdue guarantees reported [15].
证券代码：600227 证券简称：赤天化 编号：2025-016